Price$0.70-0.00 (-0.69%)
06:00 PM06:30 PM
News · 26 weeks38-50%
2025-12-072026-05-31
Mix1590d
- Insider6(40%)
- SEC Filings5(33%)
- Earnings2(13%)
- Other1(7%)
- Offering1(7%)
Latest news
25 items- SECcbdMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued MomentumCHARLOTTE, N.C. , May 14, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced financial results for the second quarter of fiscal year 2026, ended March 31, 2026. The Company delivered 19% year-over-year and 12% sequential revenue growth, reflecting continued momentum in the core business and the contribution of newly acquired Bluebird Botanicals. Quarterly revenue, excluding revenue associated with the B
- SECSEC Form 10-Q filed by cbdMD Inc.10-Q - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter ResultsCHARLOTTE, N.C., May 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 14, 2026, to discuss the company's March 31, 2026 second quarter financial results and business progress. CONFERENCE CALL DETAILSThursday, May 14, 2026, 4:20 p.m. Eastern TimeUSA/Canada:888-880-3330Webcast/Webcast Replay link - available through May 14, 2027:https://app.webinar.net/PGD52PJopeq About cbdMD, Inc.cbdMD, Inc. (NYSE:YCBD)
- PRHawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking ExperienceThe Board Expansion Is Led By Wall Street Veteran Marty Sumichrast as Chairman, In Addition to Sim Farar, Brad Fleisher, Ralph Olson, and Corby Marshall Hawkeye Systems Inc. (OTC:HWKE) ("Hawkeye" or the "Company") today announced that Martin Sumichrast has been appointed Chairman of the Board following the required waiting period under the Company's recently filed Schedule 14F-1 Information Statement. Mr. Sumichrast is joined by Sim Farar, Brad Fleisher, and Ralph Olson as fellow new members of the Board of Directors. Former Chairman & CEO Corby Marshall will remain a member of the Board. These appointments follow the appointment of David Wachsman as President of Hawkeye and mark an impor
- INSIDERSEC Form 4 filed by Porter Jeffrey H4 - cbdMD, Inc. (0001644903) (Issuer)
- INSIDERSEC Form 4 filed by Roe Kevin Charles4 - cbdMD, Inc. (0001644903) (Issuer)
- INSIDERSEC Form 4 filed by Swift Sibyl Nichole4 - cbdMD, Inc. (0001644903) (Issuer)
- INSIDERSEC Form 4 filed by Sellers Bakari T.4 - cbdMD, Inc. (0001644903) (Issuer)
- INSIDERSEC Form 4 filed by Stephen Scott G.4 - cbdMD, Inc. (0001644903) (Issuer)
- INSIDERSEC Form 4 filed by Raines William F Iii4 - cbdMD, Inc. (0001644903) (Issuer)
- SECcbdMD Inc. filed SEC Form 8-K: Other Events8-K - cbdMD, Inc. (0001644903) (Filer)
- SECcbdMD Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in MedicareCompany brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care modelsCHARLOTTE, N.C., April 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the Company to support physicians, health systems, and value-based care organizations as federal policy establishes structured pathways for hemp-derived cannabinoid products within Medicare programs.
- SECSEC Form EFFECT filed by cbdMD Inc.EFFECT - cbdMD, Inc. (0001644903) (Filer)
- SECSEC Form 424B4 filed by cbdMD Inc.424B4 - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a
- SECSEC Form 10-Q filed by cbdMD Inc.10-Q - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter ResultsCHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.
- PRcbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas MomentumCHARLOTTE, N.C., Feb. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived consumer products, today announced a major distribution expansion for its Herbal Oasis THC-infused social seltzer ("Oasis") through an expanded partnership with Morales Beverage Group ("MBG"). The agreement extends Oasis into Louisiana, strengthening the brand's regional footprint across the Gulf South and creating a more contiguous platform for continued Southeast growth, following strong early performance in Texas. With MBG's established statewide distribut
- SECSEC Form PRE 14A filed by cbdMD Inc.PRE 14A - cbdMD, Inc. (0001644903) (Filer)
- PRcbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation PathwaysCHARLOTTE, N.C., Jan. 29, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in hemp-derived wellness products, today announced a strategic initiative to integrate and expand its regulatory science, safety, and intellectual property assets to establish a differentiated cannabinoid compliance and evidence platform aligned with evolving federal healthcare evaluation frameworks, including emerging CMS and CMMI innovation initiatives. The program combines scientific and regulatory assets acquired through cbdMD's recent acquisition of Bluebird Botanicals ("Bluebird")
- SECSEC Form S-1 filed by cbdMD Inc.S-1 - cbdMD, Inc. (0001644903) (Filer)
- SECAmendment: SEC Form 10-K/A filed by cbdMD Inc.10-K/A - cbdMD, Inc. (0001644903) (Filer)
- SECSEC Form 424B3 filed by cbdMD Inc.424B3 - cbdMD, Inc. (0001644903) (Filer)
YCBD FAQ
6 questionsWhat does cbdMD Inc. do?
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as...Where does YCBD stock trade?
cbdMD Inc. (YCBD) is listed on AMEX.What sector and industry is YCBD in?
cbdMD Inc. operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.When did cbdMD Inc. go public?
cbdMD Inc. (YCBD) completed its IPO in 2017.What companies are similar to YCBD?
Notable peers in the same industry include PG (Procter & Gamble Company), UL (Unilever PLC), ECL (Ecolab Inc.), CL (Colgate-Palmolive Company), HLN (Haleon plc). Compare YCBD side-by-side with any of them on Quantisnow.How can I track YCBD on Quantisnow?
Quantisnow aggregates cbdMD Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow YCBD to receive live email and push alerts on every new disclosure.